ECSP11010850A - Nuevos compuestos adecuados como precursores de compuestos que son útiles para obtener imágenes de depósitos amiloides - Google Patents
Nuevos compuestos adecuados como precursores de compuestos que son útiles para obtener imágenes de depósitos amiloidesInfo
- Publication number
- ECSP11010850A ECSP11010850A EC2011010850A ECSP11010850A ECSP11010850A EC SP11010850 A ECSP11010850 A EC SP11010850A EC 2011010850 A EC2011010850 A EC 2011010850A EC SP11010850 A ECSP11010850 A EC SP11010850A EC SP11010850 A ECSP11010850 A EC SP11010850A
- Authority
- EC
- Ecuador
- Prior art keywords
- useful
- compounds
- deposits
- amylooid
- precursors
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 6
- 239000002243 precursor Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- 208000037259 Amyloid Plaque Diseases 0.000 abstract 2
- 210000004556 brain Anatomy 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000011503 in vivo imaging Methods 0.000 abstract 1
- 238000005259 measurement Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 238000003325 tomography Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Furan Compounds (AREA)
Abstract
La presente invención se refiere a nuevos derivados que son adecuados como precursores de compuestos útiles para obtener imágenes de depósitos amiloides en pacientes vivos, a sus composiciones, a métodos de uso y a procesos para preparar dichos compuestos. Los compuestos que derivan de estos precursores son útiles en métodos de imaginología in vivo de depósitos amiloides en el cerebro para permitir el diagnóstico ante mortem de la enfermedad de Alzheimer mediante tomografía por Pemisión de positrones (PET) así como la medición de la eficacia clínica de agentes terapéuticos para la enfermedad de Alzheimer. Además, la presente invención también divulga los compuestos precursores en forma cristalina.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9285108P | 2008-08-29 | 2008-08-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP11010850A true ECSP11010850A (es) | 2011-03-31 |
Family
ID=41721733
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2011010850A ECSP11010850A (es) | 2008-08-29 | 2011-02-28 | Nuevos compuestos adecuados como precursores de compuestos que son útiles para obtener imágenes de depósitos amiloides |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US8193363B2 (es) |
| EP (1) | EP2328891B1 (es) |
| JP (1) | JP5613669B2 (es) |
| KR (1) | KR101648848B1 (es) |
| CN (3) | CN104447710A (es) |
| AR (2) | AR073230A1 (es) |
| AU (1) | AU2009286176B2 (es) |
| BR (1) | BRPI0917147B8 (es) |
| CA (1) | CA2735497C (es) |
| CL (1) | CL2011000420A1 (es) |
| CO (1) | CO6341628A2 (es) |
| EA (1) | EA019093B1 (es) |
| EC (1) | ECSP11010850A (es) |
| ES (1) | ES2627769T3 (es) |
| IL (1) | IL211188A0 (es) |
| MX (1) | MX2011001918A (es) |
| NZ (1) | NZ591446A (es) |
| PE (1) | PE20110393A1 (es) |
| TW (1) | TW201014848A (es) |
| UY (1) | UY32076A (es) |
| WO (1) | WO2010024769A1 (es) |
| ZA (1) | ZA201102284B (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8193363B2 (en) | 2008-08-29 | 2012-06-05 | Astrazeneca Ab | Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits |
| JP5825608B2 (ja) * | 2010-08-06 | 2015-12-02 | 国立大学法人京都大学 | ピリジルベンゾフラン誘導体 |
| US10098859B2 (en) | 2012-09-05 | 2018-10-16 | Amri Ssci, Llc | Cocrystals of p-coumaric acid |
| CN107412788B (zh) | 2012-12-21 | 2021-06-18 | 国立研究开发法人量子科学技术研究开发机构 | 用于对脑内所蓄积的Tau蛋白质进行成像的新的化合物 |
| US10913736B2 (en) | 2014-08-22 | 2021-02-09 | University Of Washington | Specific inhibitors of methionyl-tRNA synthetase |
| JP2018534334A (ja) * | 2015-11-20 | 2018-11-22 | ナビディア・バイオファーマシューティカルズ，インコーポレーテッド | ２−ヘテロアリール置換ベンゾフラン類のための製剤 |
| TWI759962B (zh) | 2019-11-13 | 2022-04-01 | 香港商新旭生技股份有限公司 | 用於降解tau蛋白聚集體的化合物及其用途 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1041525A (en) | 1964-11-11 | 1966-09-07 | Belge Produits Chimiques Sa | Benzofuran derivatives and processes for preparing the same |
| CA2176127A1 (en) | 1993-12-21 | 1995-06-29 | William Henry Walker Lunn | Methods for the treatment or prevention of conditions associated with amyloidogenic reptides |
| RU2257382C2 (ru) * | 1999-10-15 | 2005-07-27 | Ф.Хоффманн-Ля Рош Аг | Производные бензодиазепина, лекарственное средство, содержащее их, и способ их получения |
| FR2800069A1 (fr) * | 1999-10-22 | 2001-04-27 | Centre Nat Rech Scient | 3-amino-2,2-di-c-alkyl-1,4-butyrolactones et 1,4- thiobutyrolactones n-substituees utiles comme stimulant de l'activite de l'acide gamma-aminobutyrique et leur procede de preparation |
| EP1351936A1 (en) | 2001-01-15 | 2003-10-15 | Glaxo Group Limited | Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression |
| JP4307001B2 (ja) | 2001-03-14 | 2009-08-05 | キヤノン株式会社 | 金属配位化合物、電界発光素子及び表示装置 |
| GB0130305D0 (en) | 2001-12-19 | 2002-02-06 | Amersham Plc | Compounds for imaging alzheimers disease |
| EP1539151B1 (en) | 2002-08-02 | 2009-03-18 | Genesoft Pharmaceuticals, Inc. | Biaryl compounds having anti-infective activity |
| EP1631561B1 (en) * | 2003-05-07 | 2010-08-18 | General Electric Company | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| US20040223912A1 (en) * | 2003-05-07 | 2004-11-11 | Montalto Michael Christopher | Compositions and methods for non-invasive imaging of soluble beta-amyloid |
| CA2530389A1 (en) | 2003-07-02 | 2005-01-13 | Biofocus Discovery Limited | Pyrazine and pyridine derivatives as rho kinase inhibitors |
| CA2573271C (en) * | 2004-07-15 | 2015-10-06 | Amr Technology, Inc. | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| US20060223849A1 (en) * | 2005-03-14 | 2006-10-05 | Mjalli Adnan M | Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors |
| CA2614116A1 (en) | 2005-07-04 | 2007-01-11 | Novo Nordisk A/S | Novel medicaments |
| US8138360B2 (en) | 2005-10-11 | 2012-03-20 | University of Pittsburgh—of the Commonwealth System of Higher Education | Isotopically-labeled benzofuran compounds as imaging agents for amyloidogenic proteins |
| TW200736252A (en) * | 2006-01-27 | 2007-10-01 | Astrazeneca Ab | Novel heteroaryl substituted benzothiazoles |
| JPWO2008068974A1 (ja) * | 2006-12-05 | 2010-03-18 | 国立大学法人 長崎大学 | オーロン誘導体含有診断用組成物 |
| JP4328820B2 (ja) | 2007-01-10 | 2009-09-09 | 田辺三菱製薬株式会社 | 医薬組成物 |
| TW200901998A (en) * | 2007-03-06 | 2009-01-16 | Astrazeneca Ab | Novel 2-heteroaryl substituted benzothiophenes and benzofuranes |
| US8193363B2 (en) | 2008-08-29 | 2012-06-05 | Astrazeneca Ab | Compounds suitable as precursors to compounds that are useful for imaging amyloid deposits |
-
2009
- 2009-08-20 US US12/544,556 patent/US8193363B2/en active Active
- 2009-08-27 UY UY0001032076A patent/UY32076A/es not_active Application Discontinuation
- 2009-08-27 TW TW098128873A patent/TW201014848A/zh unknown
- 2009-08-28 CN CN201410655681.5A patent/CN104447710A/zh active Pending
- 2009-08-28 PE PE2011000219A patent/PE20110393A1/es not_active Application Discontinuation
- 2009-08-28 WO PCT/SE2009/050972 patent/WO2010024769A1/en active Application Filing
- 2009-08-28 MX MX2011001918A patent/MX2011001918A/es active IP Right Grant
- 2009-08-28 CN CN201410653507.7A patent/CN104478862B/zh active Active
- 2009-08-28 EA EA201100267A patent/EA019093B1/ru not_active IP Right Cessation
- 2009-08-28 CN CN200980142788.7A patent/CN102197036B/zh active Active
- 2009-08-28 EP EP09810319.5A patent/EP2328891B1/en active Active
- 2009-08-28 BR BRPI0917147A patent/BRPI0917147B8/pt active IP Right Grant
- 2009-08-28 AU AU2009286176A patent/AU2009286176B2/en active Active
- 2009-08-28 NZ NZ591446A patent/NZ591446A/xx not_active IP Right Cessation
- 2009-08-28 ES ES09810319.5T patent/ES2627769T3/es active Active
- 2009-08-28 AR ARP090103323A patent/AR073230A1/es active IP Right Grant
- 2009-08-28 JP JP2011524942A patent/JP5613669B2/ja active Active
- 2009-08-28 CA CA2735497A patent/CA2735497C/en active Active
- 2009-08-28 KR KR1020117004579A patent/KR101648848B1/ko active IP Right Grant
-
2011
- 2011-02-10 IL IL211188A patent/IL211188A0/en unknown
- 2011-02-21 CO CO11020875A patent/CO6341628A2/es not_active Application Discontinuation
- 2011-02-25 CL CL2011000420A patent/CL2011000420A1/es unknown
- 2011-02-28 EC EC2011010850A patent/ECSP11010850A/es unknown
- 2011-03-28 ZA ZA2011/02284A patent/ZA201102284B/en unknown
-
2012
- 2012-06-04 US US13/487,349 patent/US8653274B2/en active Active
-
2014
- 2014-01-07 US US14/149,563 patent/US9309267B2/en active Active
-
2018
- 2018-11-12 AR ARP180103297A patent/AR114029A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY30112A1 (es) | Nuevos benzotiazoles sustitidos por heteroarilo | |
| AR114029A2 (es) | Compuestos adecuados como precursores de compuestos que son útiles para obtener imágenes de depósitos amiloides, usos y procesos | |
| WO2009155017A3 (en) | Novel substituted azabenzoxazoles | |
| ECSP099641A (es) | Nuevos benzotiofenos y benzofuranos sustituidos en la posición 2 con heteroarilo 709 | |
| UY30419A1 (es) | Nuevos benzoxazoles heteroaril sustituidos | |
| MX2016016384A (es) | Pirrolo[2,3-c]piridinas como agentes de formacion de imagenes para ovillos neurofibrilares. | |
| AR079641A1 (es) | Compuestos para el diagnostico por imagenes de la muerte de las celulas por apotosis | |
| MX2009007487A (es) | Derivados de imidazo[1,2-a]piridina substituidos de heteroarilo novedosos. | |
| BRPI0515175A (pt) | método para radiofluoração, composto, composição radiofarmacêutica, uso de um conjugado radiorrotulado ou um sal do mesmo, método para diagnose ou formação de imagem in vivo de uma doença ou condição associada com a angiogênese, e, método para monitorar o efeito do tratamento de um corpo humano ou animal com um medicamento para combater uma condição associada com cáncer | |
| EP2162054A4 (en) | ANALYSIS OF RETINAL MAP DESIGN FOR THE DIAGNOSIS OF OPTICAL NERVE DISEASES BY OPTICAL COHERENCE TOMOGRAPHY | |
| BRPI1014595A2 (pt) | procedimento de obtenção de novos derivados naftaleno para o diagnóstico in vivo de doença de alzheimer | |
| CO7131359A2 (es) | Agentes de imagen para detectar disfunción neurológica | |
| BR112014012822A8 (pt) | Radioligantes rotulados com flúor-18 e carbono-11 para imagiologia por tomografia por emissão de pósitrons (pet) para lrrk2 | |
| JP2011513306A5 (es) | ||
| WO2010051196A8 (en) | Novel substituted azabenzoxazoles | |
| SG194761A1 (en) | Radiolabeled amino acids for diagnostic imaging | |
| MX2009009113A (es) | Nuevos indoles 2-heteroaril sustituidos 695. | |
| SG194759A1 (en) | Novel precursors of glutamate derivatives | |
| WO2010096426A8 (en) | Compounds, compositions, methods of synthesis, and methods of treatment | |
| MX340487B (es) | Compuestos para usarse en la formacion de imagenes, diagnostico y/o tratamiento de enfermedades del sistema nervioso central. | |
| GB201115937D0 (en) | 18F-labelled compounds for use as positron emission imaging agents | |
| BR112013006498A2 (pt) | composto | |
| CU20090226A7 (es) | Derivados de n5-(2-etoxi-etil)-n3-(2-piridinil)-3,5-piperidin-dicarboxamida | |
| RU2015133164A (ru) | Радиоактивно-меченые соединения | |
| TH112395B (th) | สารประกอบชนิดใหม่ที่เหมาะสมเป็นพรีเคอเซอร์ไปเป็นสารประกอบที่มีประโยชน์สำหรับการถ่ายภาพการสะสมอะมัยลอยด์ |